DJIA F 23,875 50 0.21%
S&P F 2,634.00 6.50 0.25%
NASDAQ F 6,646.50 13.00 0.20%
Gold 1,312.20 6.60 0.51%
Silver 16.51 0.135 0.82%
Crude Oil 68.07 0.14 0.21%
BAYNUSClosedBack To Top
Last Updated: Mar 14, 2018 5:20 p.m. EDT Delayed quote

$ 0.01

0.00 0.00%
Previous Close
$0.01
Advanced Charting
  • $
  • %
  • Vol
Advanced Charting
573.0% vs Avg.
Volume: 1.6K 65 Day Avg. - 280.1
Open: 0.00
Close: 0.01
0 Day Low/High 0
Day Range
0.01 52 Week Low/High 0.046

Your Watchlist

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Symbol
Company
Price
Chg/Chg %
No Items in Watchlist

There are currently no items in this Watchlist.

No Saved Watchlists

Create a list of the investments you want to track.

Uh oh

Something went wrong while loading Watchlist.

Recently Viewed Tickers

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Key Data

  • Open $0.00
  • Day Range 0 - 0
  • 52 Week Range 0.01 - 0.046
  • Market Cap n/a
  • Shares Outstanding 2.16M
  • Public Float 0
  • Beta n/a
  • Rev. per Employee n/a
  • P/E Ratio n/a
  • EPS n/a
  • Yield n/a
  • Dividend n/a
  • Ex-Dividend Date n/a
  • Short Interest n/a
  • % of Float Shorted n/a
  • Average Volume 280.09

Performance

5 Day
  • 0.00%
1 Month
  • 0.00%
3 Month
  • 0.00%
YTD
  • 0.00%
1 Year
  • 0.00%

Recent News

  • MarketWatch
  • Other Dow Jones

Bayer shares climb on birth-control confirmation test

Isis Pharma to license anticlotting drug to Bayer

Bayer lifts sales forecast despite fall in profit

Bayer lifts full-year sales expectations

Bayer upbeat, plans chemicals IPO by 2016

Bayer profit falls sharply as costs bite

Bayer profit falls sharply as costs bite

Sanofi wins approval for new insulin drug

Sanofi could name Brandicourt as CEO: report

Bayer lifts earnings forecast as profit rises

Bayer profit up 14%, but outlook tweaked over euro

Merck profit up on one-time gain, lower costs

Reckitt: No longer in talks over Merck unit

Bayer's first-quarter profit jumps more than 20%

Suitors eye Merck consumer products: report

Bayer asks Japan to approve Riociguat drug

Bayer gets EU approval for lung-disease drug

Bayer plans higher dividend for 2013

Bayer gets Japan's OK for lung-disease treatment

Sanofi's Genzyme to appeal FDA Lemtraded rejection

After Paying Off Debt, Lanxess Will Take On More For Chemtura Deal

After Paying Off Debt, Lanxess Will Take On More For Chemtura Deal

  • on The Wall Street Journal

The World's Most Respected Companies

  • on Barron's
Deals of the Day: Bayer Gets Claritin, Sohn Highlights, Alibaba Looms

Deals of the Day: Bayer Gets Claritin, Sohn Highlights, Alibaba Looms

  • on The Wall Street Journal
Onyx Could Pull $150 a Share Offer Analysts Say

Onyx Could Pull $150 a Share Offer Analysts Say

  • on The Wall Street Journal

Topping Bids Unusual in Tepid M&A Market

  • on The Wall Street Journal

Reckitt’s Bid for Schiff: More Questions than Answers

  • on The Wall Street Journal

Firms Pass Up Tax Breaks, Citing Hassles, Complexity

  • on The Wall Street Journal
Champions League Final  Also Tests Financial Muscle

Champions League Final Also Tests Financial Muscle

  • on The Wall Street Journal

How to Invest in Europe (Upside)

  • on SmartMoney
Upside: Opportunities in Europe's Wreckage

Upside: Opportunities in Europe's Wreckage

  • on The Wall Street Journal
J&J Drug May Have New Role

J&J Drug May Have New Role

  • on The Wall Street Journal

FDA Overrules Staff Analysis in Approving Anticlotting Drug

  • on The Wall Street Journal

WORLD STOCK MARKETS: European Shares Kept in Check

  • on The Wall Street Journal

European Stocks Rise Tepidly

  • on The Wall Street Journal

Ad-Industry Recovery Lifts WPP's Sales

  • on The Wall Street Journal

Ad-Industry Recovery Lifts WPP's Sales

  • on The Wall Street Journal

Corporate Watch

  • on The Wall Street Journal
Superweeds Spurs Lab Work on New Seeds

Superweeds Spurs Lab Work on New Seeds

  • on The Wall Street Journal
Emerging Market Show And Tell Time For Big Pharma

Emerging Market Show And Tell Time For Big Pharma

  • on The Wall Street Journal
Miners Undo Europe; Exporters Lift Tokyo

Miners Undo Europe; Exporters Lift Tokyo

  • on The Wall Street Journal

Recent News

  • Other News
  • Press Releases

David Herro Comments on Bayer

David Herro Comments on Bayer

  • on GuruFocus.com

Company News For April 6, 2018

Companies In The News are: MON,BAYN,GMS,CYOU,ALGN

  • on Zacks.com

Key Upcoming Oncology Clinical Trial Catalysts

Key Upcoming Oncology Clinical Trial Catalysts

  • on Seeking Alpha

Biotech Analysis Central Pharma News: Regeneron's Flop, Viking's Trial Success, Biogen's MS Deal

  • on Seeking Alpha

Eaton Vance Worldwide Health Sciences Fund Buys Danaher Corp, Bayer AG, Novo Nordisk A/S, Sells ...

  • on GuruFocus.com

Biotech Analysis Central: Daily Pharma News - October 17, 2017

  • on Seeking Alpha

Eaton Vance Worldwide Health Sciences Fund Buys Boston Scientific Corp, Bayer AG, AstraZeneca ...

  • on GuruFocus.com

Nektar Makes A Stride Forward In Resolving Autoimmune Diseases

  • on Seeking Alpha

No Fruitful Harvest For Farmland Partners

  • on Seeking Alpha

David Einhorn Doesn't Think Much of Tesla, Isn't Done With General Motors

  • on GuruFocus.com

My 75 Stock January 2017 Portfolio Update: Buying 1 New Stock (Toronto-Dominion Bank) And More Cisco

  • on Seeking Alpha

SenesTech Reduces IPO Price To Stoke Investor Interest

  • on Seeking Alpha

SenesTech IPO - Humane Pest Control For The Future

  • on Seeking Alpha

Company News for September 15, 2016

  • on Zacks.com

Market Indexes Lower as Market Considers Outlook

  • on GuruFocus.com

Sensient Technologies: Buy This Market Leader In Food Colors

  • on GuruFocus.com

3 of the Best Mutual Funds to Play European Stocks

  • on InvestorPlace.com

The World's Most Respected Companies

  • on Barron's

Health Care Sector in an Upward Climb in June

  • on GuruFocus.com

Firms Pass Up Tax Breaks, Citing Hassles, Complexity

  • on The Wall Street Journal

No Headlines Available

Partner Content